TheJakartaPost
Please Update your browser
Your browser is out of date, and may not be compatible with our website. A list of the most popular web browsers can be found below.
Just click on the icons to get to the download page.
Indonesia detects more contagious British virus variant. What now?
The government reported Tuesday the first two cases of a more transmissible variant of COVID-19 that was originally discovered in the United Kingdom, one year after first local cases were discovered.
Change text size
Gift Premium Articles
to Anyone
Share the best of The Jakarta Post with friends, family, or colleagues. As a subscriber, you can gift 3 to 5 articles each month that anyone can read—no subscription needed!
Medical workers prepare to administer the coronavirus vaccine at a drive-through vaccination point in Nusa Dua on Indonesia's resort island of Bali on Monday. (Agence France Presse/Sonny Tumbelaka)
T
he Health Ministry reported on Tuesday the first two cases of a more transmissible variant of COVID-19 that was originally discovered in the United Kingdom, exactly one year after Indonesia's first local cases were discovered – making the country’s battle with the pandemic more challenging and possibly necessitating a faster vaccine rollout.
Deputy Health Minister Dante Saksono Harbuwono said on Tuesday that he had received on Monday evening a report on the detection of two cases of the British variant, known as B117.
Dante said that, with the detection of the new variant, Indonesia would need to improve its handling of the outbreak, accelerate research and expand analytical epidemiology studies.
“This means that we'll be facing the pandemic with a higher level of difficulty,” he said.
There were no details on where these cases were detected, but national COVID-19 task force spokesperson Wiku Adisasmito told The Jakarta Post that an official statement would be issued later.
Citing several studies, British scientists have said it was “likely” the variant was "associated with an increased risk of hospitalization and death" compared to infection with other non-variants of concern. The scientists revealed their analysis in a document posted last month on the UK government's website that has yet to be peer-reviewed. They meant to provide it with rapid evidence during an emergency.
The variant has been reported in at least 101 countries, according to the World Health Organization. The WHO, citing various emerging evidence, said the variant was 36 percent to 75 percent more transmissible than non-variants of concern. It has also cited studies suggesting that the mutation had no significant impact on the level of protection offered by the Moderna, Pfizer-BioNTech and Oxford-AstraZeneca vaccines.
